Chemed Co. (NYSE:CHE) Shares Bought by Fifth Third Wealth Advisors LLC

Fifth Third Wealth Advisors LLC grew its holdings in Chemed Co. (NYSE:CHE) by 22.9% in the 4th quarter, Holdings Channel reports. The institutional investor owned 584 shares of the company’s stock after buying an additional 109 shares during the quarter. Fifth Third Wealth Advisors LLC’s holdings in Chemed were worth $309,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently modified their holdings of CHE. Kayne Anderson Rudnick Investment Management LLC lifted its holdings in Chemed by 2.6% in the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 580,316 shares of the company’s stock valued at $314,868,000 after acquiring an additional 14,651 shares during the period. State Street Corp increased its holdings in shares of Chemed by 0.8% in the 3rd quarter. State Street Corp now owns 464,354 shares of the company’s stock valued at $279,063,000 after purchasing an additional 3,564 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of Chemed by 4.9% in the third quarter. Geode Capital Management LLC now owns 335,443 shares of the company’s stock valued at $201,820,000 after purchasing an additional 15,791 shares during the period. Impax Asset Management Group plc boosted its holdings in Chemed by 4.7% during the third quarter. Impax Asset Management Group plc now owns 332,757 shares of the company’s stock worth $199,977,000 after buying an additional 14,814 shares in the last quarter. Finally, FMR LLC grew its position in Chemed by 23.8% during the third quarter. FMR LLC now owns 238,616 shares of the company’s stock worth $143,401,000 after buying an additional 45,917 shares during the period. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the completion of the sale, the chief executive officer now directly owns 101,735 shares in the company, valued at $58,270,755.95. The trade was a 1.93 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Spencer S. Lee sold 732 shares of the business’s stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total transaction of $421,353.84. Following the completion of the transaction, the executive vice president now directly owns 18,287 shares of the company’s stock, valued at approximately $10,526,362.94. This represents a 3.85 % decrease in their position. The disclosure for this sale can be found here. 3.32% of the stock is currently owned by company insiders.

Chemed Trading Up 0.4 %

Shares of CHE opened at $555.01 on Friday. The company has a 50-day moving average of $545.31 and a two-hundred day moving average of $562.50. The stock has a market cap of $8.35 billion, a P/E ratio of 28.04, a PEG ratio of 2.04 and a beta of 0.47. Chemed Co. has a 12-month low of $512.12 and a 12-month high of $654.62.

Chemed (NYSE:CHE) last posted its earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). The company had revenue of $606.18 million during the quarter, compared to analysts’ expectations of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. Chemed’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same period in the previous year, the company posted $5.32 EPS. As a group, analysts forecast that Chemed Co. will post 21.43 EPS for the current fiscal year.

Chemed Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Monday, November 18th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.36%. The ex-dividend date was Monday, November 18th. Chemed’s payout ratio is currently 10.11%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on CHE shares. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, November 30th. Royal Bank of Canada decreased their target price on Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 5th.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.